Sorrento Therapeutics Announces Interim Results In Osteoarthritis Knee Pain Phase 1b Trial of Resiniferatoxin With 'Positive' Therapeutic Signal And Absence Of Dose Limiting Toxicities
Benzinga Newsdesk